Metabolite Profiles of the Serum of Patients with Non-Small Cell Carcinoma.
about
Identification of Serum Peptidome Signatures of Non-Small Cell Lung CancerStudy of early stage non-small-cell lung cancer using Orbitrap-based global serum metabolomics.Gene methylation biomarkers in sputum as a classifier for lung cancer risk.Development of LC-QTOF-MS method for human lung tissue fingerprinting. A preliminary application to nonsmall cell lung cancer.Integrated omics and gene expression analysis identifies the loss of metabolite–metabolite correlations in small cell lung cancer.Metabolome-based biomarkers: their potential role in the early detection of lung cancer
P2860
Metabolite Profiles of the Serum of Patients with Non-Small Cell Carcinoma.
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年論文
@yue
2016年論文
@zh-hant
2016年論文
@zh-hk
2016年論文
@zh-mo
2016年論文
@zh-tw
2016年论文
@wuu
2016年论文
@zh
2016年论文
@zh-cn
name
Metabolite Profiles of the Serum of Patients with Non-Small Cell Carcinoma.
@ast
Metabolite Profiles of the Serum of Patients with Non-Small Cell Carcinoma.
@en
type
label
Metabolite Profiles of the Serum of Patients with Non-Small Cell Carcinoma.
@ast
Metabolite Profiles of the Serum of Patients with Non-Small Cell Carcinoma.
@en
prefLabel
Metabolite Profiles of the Serum of Patients with Non-Small Cell Carcinoma.
@ast
Metabolite Profiles of the Serum of Patients with Non-Small Cell Carcinoma.
@en
P2093
P1476
Metabolite Profiles of the Serum of Patients with Non-Small Cell Carcinoma.
@en
P2093
Kirk L Pappan
Mary Beukemann
Meredith Seeley
Peter J Mazzone
Rob Mohney
Tracy Holt
Xiao-Feng Wang
P356
10.1016/J.JTHO.2015.09.002
P577
2016-01-01T00:00:00Z